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Abstract 
Neutrophils are important phagocytic cells for host defense against pathogens. They are 
rapidly recruited to the site of infection, release antimicrobial peptides and cytokines, and 
engulf and kill microbes. Neutrophils also accumulate in allergic inflammatory sites. Here we 
characterized neutrophil accumulation in the nasal mucosa using a mouse model of allergic 
rhinitis, in which mice were sensitized by intraperitoneal injection of ovalbumin (OVA) and 
then challenged by intranasal administration of OVA or PBS. In the nasal mucosa of both 
PBS- and OVA-challenged mice, we found a cell subset expressing the eosinophil marker 
Siglec-F in the Ly-6G+ neutrophil population. Morphological analysis of the sorted 
Ly-6G+Siglec-F+ cells revealed that they were devoid of eosinophilic granules in the cytosol 
and were apparently neutrophils, but compared to conventional Ly-6G+Siglec-F− neutrophils, 
they had a more lobulated, “botryoid” nucleus. Siglec-F+ neutrophils were barely found in the 
nasopharynx-associated lymphoid tissue, cervical lymph nodes, the spleen, or blood. Both 
Siglec-F+ neutrophils and conventional neutrophils showed increased numbers in the nasal 
mucosa of OVA-challenged mice. Compared to conventional Siglec-F− neutrophils, Siglec-F+ 
neutrophils exhibited an activated phenotype and enhanced effector functions. Taken together, 
our findings identify Siglec-F+ neutrophils as a novel neutrophil subset with an activated 
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Introduction 
The nasal tract is an important site in host defense against inhaled pathogens; it is also 
the site where allergic reactions occur to airborne allergens, resulting in diseases such as 
allergic rhinitis (AR), which is one of the most common inflammatory diseases in both 
children and adults. During the initial sensitization process in AR, allergen-specific T cells are 
activated, which orchestrate the production of allergen-specific IgE. Subsequent exposure to 
the same allergen triggers an immediate IgE-mediated mast cell response and a late-phase 
response characterized by an influx of inflammatory cells into the nasal mucosa, causing AR 
symptoms such as congestion, rhinorrhea, and sneezing [1]. The influx typically contains 
eosinophils, which play a critical role in the pathophysiology of AR [2]. They produce 
reactive oxygen species (ROS) and release their secretory granule contents, which damage the 
epithelium and promote inflammatory reactions. Although neutrophils also accumulate in the 
nasal mucosa in AR, their pathophysiological role in AR has been less established [3,4]. 
Neutrophils are important phagocytic cells for host defense against pathogens. They are 
rapidly recruited to the site of infection, release antimicrobial peptides and cytokines, and 
engulf and kill microbes through ROS production and degranulation [5]. Given their short 
lifespan and limited protein synthesis machinery, neutrophils have long been considered a 
homogenous population that does not phenotypically change. However, it is now clear that 
activation of neutrophils by cytokines such as TNF-α and bacterial compounds such as LPS 
prolongs their lifespan and induces phenotype changes. In addition, neutrophil subpopulations 
with different actions during homeostasis, infection, inflammation, and cancer have been 
reported in both humans and mice [6]. Notably, a distinct subset of neutrophils that is defined 
by its high expression of Siglec-F, a lectin normally expressed on mouse eosinophils, has been 
identified in lung tumor models [7]. Compared to conventional neutrophils, Siglec-Fhi 
neutrophils express genes associated with cancer-promoting processes. 
 
	  4 
We previously reported that the nasal mucosa was infiltrated with inflammatory cells, 
including eosinophils and lymphocytes, in a mouse AR model [8]. We also observed 
neutrophil infiltration in the nasal mucosa in this model. We found that these neutrophils were 
not a homogenous population but were comprised of the following two different subsets: a 
conventional subset and a novel subset defined by the expression of Siglec-F and CD11c. This 
Siglec-F+ neutrophil subset exhibited a characteristic appearance containing a “botryoid” 
nucleus, an activated phenotype, and enhanced effector functions. 
 
2. Materials and methods 
2.1. Mouse AR model 
The mouse AR model was prepared as described previously [8]. Briefly, on days 0, 7, 
and 14, female C57BL/6 mice (Japan SLC, Hamamatsu, Japan) were sensitized by an 
intraperitoneal injection of 25 µg of ovalbumin (OVA; Sigma-Aldrich, St. Louis, MO) and 1 
mg of alum (Imject Alum; Thermo Fischer Scientific, Waltham, MA) in 300 µl of PBS. 
Starting on day 21, the mice received a series of seven daily intranasal OVA (500 µg in PBS) 
or control PBS challenges. The mice were sacrificed 24 h after the last intranasal challenge 
for further analyses. All experimental procedures were approved by the Animal Care and Use 
Committee of Shiga University of Medical Science. 
 
2.2. Cell preparation 
Single-cell suspensions were prepared from nasopharynx-associated lymphoid tissue 
(NALT), cervical lymph nodes (CLN), and the spleen by mechanical disruption between the 
frosted ends of glass slides followed by filtration twice through a 100-µm nylon mesh. Nasal 
mucosal cells were prepared as described previously [9]. Briefly, after isolating and removing 
the NALT, nasal tissues were removed from bones and cartilages and incubated in RPMI 1640 
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containing 1 mg/ml collagenase D (Roche Diagnostics, Basel, Switzerland) for 30 min at 
37°C in a shaker incubator. The cells were washed, filtered through a 100-µm nylon mesh, 
and counted using a hemocytometer. 
 
2.3. Flow cytometry 
The monoclonal antibodies (mAbs) used for the flow cytometry analyses were purchased 
from BD Biosciences (San Jose, CA), eBioscience (San Diego, CA), or BioLegend (San 
Diego, CA) and included antibodies to CD11a (M17/4), CD11b (M1/70), CD11c (N418), 
CD18 (M18/2), CD29 (HMβ1-1), CD45 (30-F11), CD49d (R1-2), CD54 (YN1/1.7.4), CD62L 
(MEL-14), CCR1 (S15040E), CCR2 (SA203G11), CCR3 (J073E5), CXCR2 (SA044G4), 
Ly-6G (1A8), and Siglec-F (E50-2440). Single-cell suspensions were incubated with 
anti-CD16/CD32 (2.4G2) for 10 min, followed by staining with mAbs for 30 min on ice and 
washing. Data were acquired on a FACSCantoII (BD Biosciences) and analyzed using the 
FlowJo software. Conventional neutrophils (CD45+Ly-6G+Siglec-F−CD11c−), Siglec-F+ 
neutrophils (CD45+Ly-6G+Siglec-F+CD11c+), and eosinophils 
(CD45+Ly-6GloSiglec-F+CD11c−) were sorted using a FACSAria (BD Biosciences). Sorted 
cells were subjected to cytospin followed by May–Grünwald–Giemsa staining. 
 
2.4. Histology 
Tissue samples were prepared as described previously [10]. Briefly, the maxilla and 
nasal cavities were dissected, fixed overnight in 1% paraformaldehyde and 10% EDTA in 
PBS, and decalcified in 10% EDTA in PBS for 10–14 days. Tissues were then washed with 
20% sucrose in PBS, embedded in OCT compound (Sakura Finetek Japan, Tokyo, Japan), and 
frozen. Sections were cut, rehydrated in PBS, and blocked with donkey serum in 2% BSA in 
PBS followed by a Streptavidin/Biotin Blocking Kit (Vector Laboratories, Burlingame, CA) 
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for 15 min each. Sections were incubated overnight with goat anti–Siglec-F (R&D systems, 
Minneapolis, MN) at 4°C followed by incubation with Alexa Fluor 488–labeled donkey 
anti-goat IgG for 1 h, and blocked again with goat IgG in 2% BSA in PBS. Sections were then 
incubated overnight with Alexa Fluor 647–labeled anti–Ly-6G followed by incubation with 
Alexa Fluor 647–labeled goat anti-rat IgG, and then incubated with DAPI. Sections were 
mounted with ProLong Gold Antifade Reagent (Thermo Fisher Scientific), and observed 
under a spectral confocal microscope (C1si; Nikon, Tokyo, Japan). 
 
2.5. Quantification of ROS and phagocytosis 
For ROS measurement, sorted cells were stimulated with or without 300 ng/ml LPS 
(Sigma-Aldrich) for 4 h. Stimulated cells were incubated with 25 µM CM-H2DCFDA 
(Invitrogen, Carlsbad, CA) for 30 min at 37°C and analyzed by flow cytometry. A 
phagocytosis assay was performed using pHrodo Green E. coli BioParticles Conjugate 
(Invitrogen) according to the manufacturer’s instructions. Briefly, single-cell suspensions 
prepared from the nasal mucosa were incubated with pH-sensitive fluorescent particles 
resuspended at 1 mg/ml in PBS. After 30 min incubation at 37°C or on ice, phagocytosis was 
stopped by the addition of ice-cold PBS and cells were placed on ice. Cells were then stained 
for CD45, Ly-6G, Siglec-F, and CD11c. Data were acquired on a FACSCantoII and analyzed 
using the FlowJo software. 
 
2.6. Stimulation of conventional neutrophils 
Spleen cells were incubated with or without 300 ng/ml LPS for 4 h. The cells were then 
stained for Siglec-F, CD11c, and CD54 and analyzed by flow cytometry. 
 
2.7. Statistical analysis 
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Statistical analysis was performed using the two-tailed Student’s t test. 
 
3. Results 
3.1. Siglec-F+ neutrophils accumulate in the nasal mucosa 
 We previously showed that the nasal mucosa was massively infiltrated by inflammatory 
cells, including eosinophils and lymphocytes, in a mouse AR model [8]. As neutrophils also 
accumulated, we further characterized granulocyte populations infiltrating the nasal mucosa. 
For the AR model, C57BL/6 mice were systemically immunized with intraperitoneal 
injections of OVA and then challenged for seven consecutive days with intranasal 
administrations of OVA or control PBS. We prepared single-cell suspensions from the nasal 
mucosa of the mice sacrificed 24 h after the last intranasal challenge, and analyzed them by 
flow cytometry using the neutrophil marker Ly-6G and the eosinophil marker Siglec-F. 
Among the CD45+ leukocytes, a side scatter (SSC)hiLy-6Glo population was markedly 
increased in frequency in OVA-challenged mice (Fig. 1A). These cells were mostly 
Siglec-F+CD11clo and likely eosinophils [11]. Indeed, May–Grünwald–Giemsa staining of the 
sorted cells in this gate (gate I) confirmed that they were eosinophils with ring-shaped nuclei 
and eosinophilic granules in the cytoplasm (Fig. 1B). Ly-6Ghi cells in the nasal mucosa 
contained the following two populations: Siglec-F−CD11c− (gate II) and Siglec-F+CD11c+ 
(gate III). Siglec-F is an eosinophil marker that is not normally expressed on neutrophils [12]. 
The morphology of sorted Ly-6GhiSiglec-F−CD11c− cells is consistent with that of 
conventional mouse neutrophils with ring-shaped nuclei (Fig. 1B). Although 
Ly-6GhiSiglec-F+CD11c+ cells are also morphologically neutrophils with a neutrally stained 
cytoplasm, they had segmented nuclei (Fig. 1B). These two neutrophil populations are 
referred here as Siglec-F− and Siglec-F+ neutrophils. Notably, the segmented nuclei of 
Siglec-F+ neutrophils were radially arranged with spokelike filaments, morphologically 
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resembling those of “botryoid” neutrophils observed in human blood during heat stroke 
[13,14]. Siglec-F+ neutrophils from OVA-challenged mice were larger and had more 
prominent blebs than those from PBS-challenged mice. The peripheral blood of PBS- or 
OVA-challenged mice contained eosinophils and Siglec-F− neutrophils, both of which 
exhibited a similar morphology to the corresponding populations in the nasal mucosa (Fig. 1C, 
D). In contrast, Siglec-F+ neutrophils were barely found in the blood from either PBS- or 
OVA-challenged mice (Fig. 1C). They were also barely present in lymphoid tissues, including 
the NALT, CLN, and spleen (Fig. 1E). To examine whether this subset resides in mucosal 
tissue other than the nasal mucosa, we isolated cells from the small intestinal mucosa and 
analyzed them by flow cytometry. Ly-6Ghi neutrophils were much less frequent than 
eosinophils in the intestinal mucosa, and most of them were Siglec-F−CD11c− (Fig. S1). Thus, 
Siglec-F+ neutrophils are a subset that specifically resides in the nasal mucosa. 
As expected, the number of eosinophils in the nasal mucosa was remarkably increased in 
OVA-challenged mice compared to PBS-challenged mice (Fig. 1F). Albeit less abundant than 
eosinophils, both Siglec-F− and Siglec-F+ neutrophils were also increased in the nasal mucosa 
upon OVA challenge (Fig. 1F). 
Immunofluorescence staining of nasal mucosa sections revealed the presence of cells 
expressing both Ly-6G and Siglec-F in both PBS- and OVA-challenged mice, which were 
likely Siglec-F+ neutrophils (Fig. 2A). Ly-6G+Siglec-F+ cells accumulated in the same region 
where Ly-6G+Siglec-F− cells (Siglec-F− neutrophils) and Ly-6G−Siglec-F+ cells (eosinophils) 
accumulated. In agreement with the flow cytometry results, Ly-6G+Siglec-F+ cells were more 
abundant in the nasal mucosa from OVA-challenged mice than from PBS-challenged mice. In 
contrast, Ly-6G+Siglec-F+ cells were hardly found in the NALT and spleen sections from 
either PBS- or OVA-challenged mice (Fig. 2B), again confirming that Siglec-F+ neutrophils 
are a unique subset that resides in the nasal mucosa. 
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3.2. Siglec-F+ neutrophils exhibit an activated phenotype 
To characterize Siglec-F+ neutrophils, we examined the cell surface expression of 
adhesion molecules known to be involved in neutrophil activation and migration. Neutrophils 
express β2 integrins such as LFA-1 (αLβ2; CD11a/CD18) and Mac-1 (αMβ2; CD11b/CD18). In 
PBS-challenged mice, the expression of CD11a on Siglec-F+ neutrophils was lower than that 
on conventional Siglec-F− neutrophils, while CD18 expression was higher on Siglec-F+ 
neutrophils (Fig. 3A, B). In addition to β2 integrins, the α4 integrin VLA-4 (α4β1; 
CD49d/CD29) is also expressed on neutrophils. The expression of CD49d was higher on 
Siglec-F+ neutrophils than on Siglec-F− neutrophils in both PBS- and OVA-challenged mice. 
Most notably, ICAM-1 (CD54), a member of the Ig-like gene superfamily, which is generally 
absent on circulating neutrophils, was considerably expressed on Siglec-F+ neutrophils but 
only minimally expressed on Siglec-F− neutrophils. Furthermore, CD54 expression on 
Siglec-F+ neutrophils was upregulated upon OVA challenge. Another remarkable feature of 
Siglec-F+ neutrophils is the downregulation of L-selectin (CD62L), which is known to be 
shed in response to activation. These results suggested that Siglec-F+ neutrophils in the nasal 
mucosa exhibit adhesion molecule expression profiles typical of activated neutrophils. 
We next investigated chemokine receptor expression profiles. Siglec-F+ neutrophils did 
not express CCR3, a chemokine receptor selectively expressed on eosinophils, but expressed 
CCR1, CCR2, and CXCR2, which mediate neutrophil migration (Fig. 3C). CXCR2 was 
apparently upregulated in Siglec-F+ neutrophils compared to Siglec-F− neutrophils in the 
nasal mucosa of OVA-challenged mice. 
 
3.3. Siglec-F+ neutrophils have increased phagocytic activity 
To understand the functional roles of Siglec-F+ neutrophils, we evaluated the capacity of 
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the three granulocyte subsets to produce ROS. Eosinophils, Siglec-F− neutrophils, and 
Siglec-F+ neutrophils were isolated from the nasal mucosa of OVA-challenged mice and 
stimulated with or without LPS. LPS-induced ROS generation was measured using the 
ROS-sensitive fluorescent probe CM-H2DCFDA by flow cytometry. Siglec-F+ neutrophils 
showed a tendency toward increased ROS generation, although there were no significant 
differences among the three subsets (Fig. 4A). 
We next measured the phagocytic activity of the three granulocyte subsets in the nasal 
mucosa of PBS- and OVA-challenged mice using fluorescent E. coli particles. As expected, 
compared to the two neutrophil subsets, eosinophils showed only minimal phagocytic activity 
(Fig. 4B, C). Compared to Siglec-F− neutrophils, Siglec-F+ neutrophils from both PBS- and 
OVA-challenged mice showed significantly higher phagocytosis activity (Fig. 4B, C). 
Collectively, these results demonstrate that Siglec-F+ neutrophils had enhanced effector 
functions. 
 
3.4. Stimulation of Siglec-F− neutrophils in vitro induces only a slight increase in Siglec-F 
expression 
Having identified an activated phenotype of Siglec-F+ neutrophils, we evaluated whether 
Siglec-F− neutrophils could be converted to Siglec-F+ neutrophils by stimulating these cells in 
vitro. LPS stimulation of Siglec-F− neutrophils from the spleen induced the upregulation of 
cell surface expression of Siglec-F, CD11c, and CD54 (Fig. 4D). However, the increase in 
Siglec-F expression was only minimal, suggesting that Siglec-F+ neutrophils cannot be 
generated simply by stimulating conventional neutrophils. 
 
4. Discussion 
In this study, we identified a novel neutrophil subset that specifically resides in the nasal 
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mucosa and accumulates during nasal inflammation in a mouse AR model. These neutrophils 
expressed Siglec-F and exhibited an activated phenotype and enhanced effector functions. 
Conventional mouse neutrophils in the bone marrow and blood have ring-shaped nuclei 
rather than segmented nuclei [15]. These neutrophils were also constitutively present in the 
nasal mucosa and accumulated under inflammatory conditions. In addition to these 
conventional neutrophils, the nasal mucosa contained a distinct neutrophil population defined 
by the expression of Siglec-F. Remarkably, Siglec-F+ neutrophils had radially segmented, 
“botryoid” nuclei. Radial segmentation is caused by contractile microfilaments and 
microtubules radiating from the centriole [16] and appears to be associated with inflammatory 
conditions [17]. In humans, botryoid neutrophils have been reported in patients with heat 
stroke [13,14], encephalitis [18], and cocaine abuse [19]. Although it is not known whether 
botryoid changes were induced in situ in the nasal mucosa, nuclear segmentation implies 
increased maturation of Siglec-F+ neutrophils.  
The subset is characterized by unique cell surface expression profiles of adhesion 
molecules (CD11c+CD54+CD62Llo), indicating an activated phenotype. Indeed, compared to 
conventional neutrophils, Siglec-F+ neutrophils exhibited enhanced phagocytosis and a 
tendency toward increased ROS generation. It has been reported that in a mouse model of 
endotoxemia, CD54-expressing neutrophils exhibit enhanced phagocytosis and ROS 
generation and that CD54 expression correlates with these effector functions [20]. Engblom et 
al. [7] reported that Siglec-Fhi neutrophils infiltrating lung tumors in a mouse tumor model 
showed increased ROS activity. Furthermore, gene expression profiles showed that CD11c 
(Itgax) and CD54 (Icam1) were upregulated while CD11a (Itgal) was downregulated in 
Siglec-Fhi neutrophils compared to Siglec-Flo neutrophils, suggesting that nasal Siglec-F+ 
neutrophils and lung tumor–infiltrating Siglec-Fhi neutrophils have overlapping phenotypes 
and functions. In humans, the following three neutrophil subsets are found in the blood during 
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acute inflammation: neutrophils with a conventional segmented nucleus, neutrophils with a 
banded nucleus, and CD62Llo neutrophils with a hypersegmented nucleus [21,22]. Siglec-F+ 
neutrophils phenotypically resemble human CD62Llo neutrophils, which are also 
CD11c+CD54+. Functionally, human CD62Llo neutrophils inhibit T cell responses and thereby 
maintain tolerance [21]. Conversely, CD62Llo neutrophils reported in the nasal lavage fluid 
from allergic patients exhibit a T cell priming capacity and enhance eosinophil migration [23]. 
It remains to be determined whether Siglec-F+ neutrophils in the nasal mucosa have any 
interactions with T cells and promote or inhibit allergic inflammation. In this regard, during 
intestinal mucosal inflammation, a functionally activated neutrophil subset negatively 
regulates the pathogenesis of inflammatory bowel disease [24]. 
The origin of Siglec-F+ neutrophils also remains elusive. We showed that stimulation of 
Siglec-F− neutrophils with LPS induced only a slight increase in the expression of Siglec-F. It 
may thus be less likely that Siglec-F− neutrophils simply convert into the Siglec-F+ neutrophil 
subset upon stimulation. It has been proposed that human CD62Llo neutrophils are a separate 
neutrophil subset based on proteome profiling and in vivo pulse-chase labeling [22]. Lung 
tumor–infiltrating Siglec-Fhi neutrophils acquire their molecular features before arrival at the 
tumor site [7]. Whether the Siglec-F+ subset is generated from conventional neutrophils in situ 
in the nasal environment or elsewhere before arrival at the nasal mucosa will be determined. 
In conclusion, our study shows a distinct subset of neutrophils residing specifically in the 
mouse nasal mucosa. They exhibit an activate phenotype and enhanced effector functions. 
Further investigation will be required to clarify the functional role and origin of this subset. 
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Fig. 1.  Two neutrophil subsets are observed in the nasal mucosa. (A) Expression of Ly-6G, 
Siglec-F, and CD11c in CD45+ cells in the nasal mucosa from PBS- or OVA-challenged mice. 
Gate I, SSChiLy-6GloSiglec-F+CD11clo cells (eosinophils); gate II, Ly-6GhiSiglec-F−CD11c− 
cells (conventional Siglec-F− neutrophils); and gate III, Ly-6GhiSiglec-F+CD11c+ cells 
(Siglec-F+ neutrophils). (B) May–Grünwald–Giemsa staining of sorted cells in gates I, II, and 
III shown in (A). Scale bar, 10 µm. (C) Expression of Ly-6G, Siglec-F, and CD11c in CD45+ 
cells in the blood from PBS- or OVA-challenged mice. (D) May–Grünwald–Giemsa staining 
of sorted cells in gates I and II shown in (C). Scale bar, 10 µm. (E) Expression of Siglec-F and 
CD11c in Ly-6Ghi neutrophils in the NALT, CLN, and spleen from PBS- or OVA-challenged 
mice. (F) The number of eosinophils (I), Siglec-F− neutrophils (II), and Siglec-F+ neutrophils 
(III) in the nasal mucosa from PBS- or OVA-challenged mice. Data (mean ± SEM) represent 
the results from three mice per group. *p < 0.05, **p < 0.01. 
 
Fig. 2.  Siglec-F+ neutrophils are located in the nasal lamina propria. Immunofluorescence 
staining of nasal mucosa sections (A) and NALT and spleen sections (B) from PBS- or 
OVA-challenged mice. Frozen sections were stained for Ly-6G (red), Siglec-F (green), and 
DAPI (blue). Arrowheads indicate cells co-expressing Ly-6G and Siglec-F. Squares in the 
images on the left in each panel correspond to the images on the right. Scale bars, 50 µm (left 
images) and 10 µm (right images). 
 
Fig. 3.  Siglec-F+ neutrophils exhibit an activated phenotype. (A) Expression of 
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representative adhesion molecules in eosinophils (I), Siglec-F− neutrophils (II), and Siglec-F+ 
neutrophils (III) in the nasal mucosa from PBS- or OVA-challenged mice. Representative 
staining results with mAbs to indicated adhesion molecules (open graphs) and isotype 
controls (shaded graphs) are shown. (B) Quantitative analysis of expression of representative 
adhesion molecules. Data (mean ± SEM) are expressed as the mean fluorescence intensity 
(MFI) and represent the results from three mice per group. *p < 0.05, **p < 0.01, ***p < 
0.001. (C) Expression of representative chemokine receptors in eosinophils (I), Siglec-F− 
neutrophils (II), and Siglec-F+ neutrophils (III) in the nasal mucosa from PBS- or 
OVA-challenged mice. Representative staining results with mAbs to indicated chemokine 
receptors (open graphs) and isotype controls (shaded graphs) are shown. 
 
Fig. 4.  Siglec-F+ neutrophils exhibit enhanced effector functions. (A) ROS production in 
eosinophils (I), Siglec-F− neutrophils (II), and Siglec-F+ neutrophils (III) in the nasal mucosa 
from OVA-challenged mice. Data (mean ± SEM) are expressed as the MFI increase calculated 
by subtracting the average of MFI of unstimulated cells from the MFI of LPS-stimulated cells 
and represent the results from four mice. (B) Phagocytic activity of eosinophils (I), Siglec-F− 
neutrophils (II), and Siglec-F+ neutrophils (III) in the nasal mucosa from PBS- or 
OVA-challenged mice. Representative flow cytometry histograms of E. coli uptake are shown. 
(C) Quantitative analysis of phagocytic activity. Data (mean ± SEM) are expressed as the MFI 
and represent the results from three mice per group. *p < 0.05. (D) Expression of Siglec-F, 
CD11c, and CD54 in Siglec-F– neutrophils stimulated with or without LPS. Data (mean ± 
SEM) are expressed as the MFI and represent the results from three mice per group. *p < 0.05, 















































































































































































































































































































































































































































Fig. S1. Siglec-F+ neutrophils are barely observed in the small intestine. Expression of 
Ly-6G, Siglec-F, and CD11c in CD45+ cells in the small intestine from PBS- or 
OVA-challenged mice is shown. 
